Bibliometric analysis of scientific papers on adverse reactions to COVID-19 vaccines published between 2019 and 2023

Hum Vaccin Immunother. 2023 Dec 15;19(3):2270194. doi: 10.1080/21645515.2023.2270194. Epub 2023 Oct 27.

Abstract

The Coronavirus Disease 2019 (COVID-19) pandemic has now persisted globally for four years, resulting in a staggering death toll of over 4 million individuals. The COVID-19 vaccine has emerged as a highly effective tool in controlling the spread of this virus. However, as the number of individuals receiving COVID-19. In this context, the investigation of adverse reactions related to COVID-19 vaccines holds paramount importance in relevant research. The purpose is to evaluate the current research status regarding adverse reactions associated with COVID-19 vaccines, offering insights for future research. A total of 3,746 articles were included in this analysis, and there has been a notable upward trajectory in the volume of published articles. The CiteSpace v6.1.R6, VOSviewer, SCImago Graphica, and Excel 2019 were employed to analyze and visualize the results. The institutions, countries, journals, authors, co-cited references, and keywords of these articles were analyzed. Furthermore, this study delves into the characteristics of articles on adverse reactions associated with COVID-19 vaccines. It was observed that the number of studies on COVID-19 vaccines has increased year by year since 2019 and witnessed a surge in output in 2021. The vast majority of studies have affirmed the overall safety of COVID-19 vaccines, with adverse reactions tending to be more concentrated in specific diseases. These findings provide valuable ideas for future research in this field and suggest the importance of strengthening international cooperation on adverse reactions to COVID-19 vaccines.

Keywords: COVID-19; Citespace; WoSCC; bibliometrics; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bibliometrics
  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • International Cooperation
  • Pandemics / prevention & control

Substances

  • COVID-19 Vaccines

Grants and funding

This study was supported by a grant from the Wisdom Accumulation and Talent Cultivation Project of the Third xiangya hospital of Central South University [YX202212].